Appia Bio
Collaborates across a diversity of disciplines, which is critical to developing next-generation therapies for patients
13 employees · est. 2020
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine learning
26 employees · est. 2019 · Cambridge, United States
Thymmune Therapeutics is the older company (2020 vs 2019).
Side-by-Side Comparison
| Metric | Appia Bio | Thymmune Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2019 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Cambridge, United States |
| Employees | ||
| Employees | 13 | 26 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Seed |
| Total Funding | ||
| Total Funding | $52.00M | $44.30M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Not tracked yet | Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with immune-mediated diseases, Individuals with immunodeficiencies, Patients experiencing age-related immune decline, Healthcare professionals seeking innovative treatments |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Allogeneic Cell Therapy, Engineered Cell Therapy, ACUA Technology Platform, CAR-iNKT Cells, Invariant Natural Killer T Cells, Hematopoietic Stem Cells, Lymphocyte Development, CAR Gene Engineering, TCR Gene Engineering, Chimeric Antigen Receptor, T-cell Receptor | Thymic Cell Therapies, IPSC Manufacturing, Immunotherapy, Immune Restoration, Aging, Disease Treatment, Immunodeficiencies, Transplant Therapeutics, Autoimmune Diseases, Cell Engineering, Off-the-shelf Therapies, Therapeutic Pipeline, Biotech Innovation |
| Website | ||
| Website | appiabio.com | thymmune.com |
About Appia Bio
Appia Bio, an early-stage biotechnology company located in Los Angeles, California, was founded in 2020. The company's core focus is on creating and developing engineered allogeneic cell therapies that target a wide range of medical indications through its innovative and scalable platform, ACUA (App...
About Thymmune Therapeutics
Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to p...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Appia Bio and Thymmune Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Appia Bio and Thymmune Therapeutics — by email.
Frequently Asked Questions
Compare Appia Bio with someone else
Start typing a company name or domain.